A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects with Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation

Clinical Trial Grant

Duke Scholars

Principal Investigator Richard Stanley Bedlack Neurology, Neuromuscular Disease

Administered By

Neurology

Awarded By

Neuraltus Pharmaceuticals, Inc

Start Date

August 1, 2016

End Date

October 10, 2018

Administered By

Neurology

Awarded By

Neuraltus Pharmaceuticals, Inc

Start Date

August 1, 2016

End Date

October 10, 2018